Magellan Health, Inc. (MGLN) Financials

NASDAQ Currency in USD Disclaimer

$94.99

north_east NA Past Year
Day's range
$94.99
Day's range
$94.99
$8B$8B$6B$6B$4B$4B$2B$2B$0$0Earning201420142015201520162016201720172018201820192019202020202%2%1.5%1.5%1%1%0.5%0.5%0%0%Profit Margin
Profit Margin
Revenue
Earnings

MGLN Income statement / Annual

Last year (2020), Magellan Health, Inc.'s total revenue was $4.58 B, a decrease of 36.06% from the previous year. In 2020, Magellan Health, Inc.'s net income was $4.05 M. See Magellan Health, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012 FY-2011
Period Ended 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012 12/31/2011
Operating Revenue $4.58 B $7.16 B $7.31 B $5.84 B $4.84 B $4.60 B $3.76 B $3.55 B $3.21 B $2.80 B
Cost of Revenue $4.46 B $6.93 B $7.12 B $5.57 B $4.58 B $4.42 B $3.55 B $3.31 B $2.96 B $2.02 B
Gross Profit $118.79 M $229.29 M $197.18 M $271.02 M $258.94 M $178.38 M $215.08 M $238.19 M $249.58 M $782.64 M
Gross Profit Ratio 0.03 0.03 0.03 0.05 0.05 0.04 0.06 0.07 0.08 0.28
Research and Development Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $876.61 M $822.39 M $723.50 M $619.55 M $557.51 M $529.63 M
Other Expenses $98.39 M $131.51 M $132.66 M $115.71 M -$770.57 M -$719.55 M -$632.43 M -$547.55 M -$497.02 M $58.62 M
Operating Expenses $98.39 M $131.51 M $132.66 M $115.71 M $106.05 M $102.84 M $91.07 M $71.99 M $60.49 M $588.26 M
Cost And Expenses $4.56 B $7.06 B $7.25 B $5.68 B $4.68 B $4.52 B $3.64 B $3.38 B $3.02 B $2.61 B
Interest Income $4.05 M $19.19 M $14.07 M $5.89 M $2.82 M $2.17 M $1.30 M $1.99 M $2.02 M $2.78 M
Interest Expense $30.87 M $36.15 M $35.40 M $25.98 M $10.19 M $6.58 M $7.39 M $3.00 M $2.25 M $2.50 M
Depreciation & Amortization $118.75 M $131.51 M $132.66 M $115.71 M $106.05 M $102.84 M $91.07 M $71.99 M $60.49 M $58.62 M
EBITDA $487.41 M $248.48 M $211.25 M $276.97 M $263.85 M $183.25 M $221.55 M $240.18 M $251.60 M $255.79 M
EBITDA Ratio 0.11 0.03 0.03 0.05 0.05 0.04 0.06 0.07 0.08 0.09
Operating Income Ratio 0.08 0.02 0.01 0.03 0.03 0.02 0.03 0.05 0.06 0.07
Total Other Income/Expenses Net -$409.15 M -$36.15 M -$35.40 M -$26.04 M -$12.28 M -$9.29 M -$12.56 M -$3.00 M -$2.25 M -$2.50 M
Income Before Tax -$40.49 M $80.82 M $43.19 M $135.22 M $145.52 M $71.12 M $117.92 M $165.19 M $188.87 M $194.66 M
Income Before Tax Ratio -0.01 0.01 0.01 0.02 0.03 0.02 0.03 0.05 0.06 0.07
Income Tax Expense -$44.53 M $24.92 M $19.01 M $25.08 M $69.73 M $42.41 M $43.69 M $39.92 M $37.84 M $65.04 M
Net Income $4.05 M $55.90 M $24.18 M $110.14 M $75.79 M $28.71 M $74.23 M $125.26 M $151.03 M $129.62 M
Net Income Ratio 0 0.01 0 0.02 0.02 0.01 0.02 0.04 0.05 0.05
EPS 0.16 2.28 0.97 4.72 3.27 1.15 2.78 4.63 5.51 4.25
EPS Diluted 0.16 2.28 0.97 4.51 3.14 1.11 2.71 4.53 5.42 4.17
Weighted Average Shares Out $25.78 M $24.56 M $25.04 M $23.33 M $23.18 M $24.87 M $26.69 M $27.05 M $27.39 M $30.48 M
Weighted Average Shares Out Diluted $25.78 M $24.56 M $25.04 M $24.44 M $24.16 M $25.88 M $27.36 M $27.68 M $27.88 M $31.06 M
Link